Definitive Contract W81XWH15C0063
Award Date 9/24/15
Potential Completion Date 1/24/18
Potential Value $5M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Takeda Pharmaceuticals America Inc. received a delivery order valued at $28,111.59 from Veterans Integrated Service Network 12 for MARIBAVIR (LIVTENCITY), an antiviral pharmaceutical for transplant-related infections. This firm fixed-price delivery order, awarded on February 4, 2026, with an ultimate completion date of April 3, 2026, represents a child contract under the General Services Administration Pharmaceuticals and Drugs Schedule (FSS-61-IB). The award was not designated with a...
- This is a $3,735,479.26 firm fixed price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Novadigm Therapeutics, Inc. for an Infectious Disease Clinical Research Program (IDCRP) study on a Staphylococcus vaccine. The contract has a period of performance ending on January 31, 2020 and was awarded on September 16, 2016. The place of performance is Grand Forks, North Dakota. Novadigm Therapeutics, Inc. is a for-profit organization and the prime contractor for this award....
- The federal contract award, identified as SPE2DX15D7062|SPE2DX25FJCJV, is for the delivery of 4566618130 units of Typhoid Vaccine 25mcg, with a firm fixed price of $13,427.84 and an ultimate completion date of January 3, 2025. The contract was awarded on December 5, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. This contract is not designated as a...
- <p>This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Novartis Vaccines and Diagnostics, Inc. for the purchase of NOVARTIS VACCINES FOR STOCK. The contract has an ultimate completion date of June 24, 2015 and a ceiling value of $87,334.00. It was awarded on May 27, 2015 and is not associated with a set-aside program. The contract is under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB).</p>
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Vaccines and Diagnostics, Inc. for the delivery of flu vaccines. The contract has a ceiling value of $114,400.00 and was awarded on June 22, 2015, with a final completion date of December 31, 2015. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Novartis Vaccines and Diagnostics, Inc. is the prime contractor, and the place of...
- This is a firm fixed-price delivery order awarded to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of specialized pharmaceutical products. The $122,177.34 contract was issued by the Federal Correctional Institution in Fort Worth, Texas, a civilian agency, under the General Services Administration (GSA) Schedule 61 for Pharmaceuticals and Drugs. The order is for a variety of medications, including those used to treat rare diseases, hemophilia, immunological...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Vaccines And Diagnostics, Inc. for the delivery of drugs and biologicals. The contract has a ceiling value of $262,467.00 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation. The award was made on May 16, 2007, with an ultimate completion date of September 11, 2007. The place of performance is Phoenix, Arizona. Novartis Vaccines And Diagnostics, Inc. is a...
- The Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order valued at $18,720.00 to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for the provision of VONVENDI medication for patient treatment. This order was placed against Takeda's existing Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The order has an ultimate completion date of December 31, 2024 and was awarded on March 1, 2024. Takeda...
- This is a $2,785.15 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The contract is not designated under any set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, was awarded a delivery order valued at $112,528.26 on February 5, 2025, for the supply of bulk Maribavir 200mg tablets, with a price adjustment reflecting two bottles. The contract is a firm fixed-price delivery order under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries no set-aside designation. The award is being funded by Veterans...